Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E

Yuqing Huo, Andreas Schober, S. Bradley Forlow, David F. Smith, Matthew Craig Hyman, Steffen Jung, Dan R. Littman, Christian Weber, Klaus Ley

Research output: Contribution to journalArticle

753 Citations (Scopus)

Abstract

We studied whether circulating activated platelets and platelet-leukocyte aggregates cause the development of atherosclerotic lesions in apolipoprotein-E-deficient (Apoe-/-) mice. Circulating activated platelets bound to leukocytes, preferentially monocytes, to form platelet-monocyte/leukocyte aggregates. Activated platelets and platelet-leukocyte aggregates interacted with atherosclerotic lesions. The interactions of activated platelets with monocytes and atherosclerotic arteries led to delivery of the platelet-derived chemokines CCL5 (regulated on activation, normal T cell expressed and secreted, RANTES) and CXCL4 (platelet factor 4) to the monocyte surface and endothelium of atherosclerotic arteries. The presence of activated platelets promoted leukocyte binding of vascular cell adhesion molecule-1 (VCAM-1) and increased their adhesiveness to inflamed or atherosclerotic endothelium. Injection of activated wild-type, but not P-selectin-deficient, platelets increased monocyte arrest on the surface of atherosclerotic lesions and the size of atherosclerotic lesions in Apoe-/- mice. Our results indicate that circulating activated platelets and platelet-leukocyte/monocyte aggregates promote formation of atherosclerotic lesions. This role of activated platelets in atherosclerosis is attributed to platelet P-selectin-mediated delivery of platelet-derived proinflammatory factors to monocytes/leukocytes and the vessel wall.

Original languageEnglish (US)
Pages (from-to)61-67
Number of pages7
JournalNature Medicine
Volume9
Issue number1
DOIs
StatePublished - Jan 1 2003
Externally publishedYes

Fingerprint

Apolipoproteins E
Platelets
Atherosclerosis
Blood Platelets
Monocytes
Leukocytes
P-Selectin
Endothelium
Arteries
Platelet Factor 4
Adhesiveness
Chemokine CCL5
T-cells
Vascular Cell Adhesion Molecule-1

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Huo, Y., Schober, A., Forlow, S. B., Smith, D. F., Hyman, M. C., Jung, S., ... Ley, K. (2003). Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nature Medicine, 9(1), 61-67. https://doi.org/10.1038/nm810

Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. / Huo, Yuqing; Schober, Andreas; Forlow, S. Bradley; Smith, David F.; Hyman, Matthew Craig; Jung, Steffen; Littman, Dan R.; Weber, Christian; Ley, Klaus.

In: Nature Medicine, Vol. 9, No. 1, 01.01.2003, p. 61-67.

Research output: Contribution to journalArticle

Huo, Y, Schober, A, Forlow, SB, Smith, DF, Hyman, MC, Jung, S, Littman, DR, Weber, C & Ley, K 2003, 'Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E', Nature Medicine, vol. 9, no. 1, pp. 61-67. https://doi.org/10.1038/nm810
Huo, Yuqing ; Schober, Andreas ; Forlow, S. Bradley ; Smith, David F. ; Hyman, Matthew Craig ; Jung, Steffen ; Littman, Dan R. ; Weber, Christian ; Ley, Klaus. / Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. In: Nature Medicine. 2003 ; Vol. 9, No. 1. pp. 61-67.
@article{214994489537473ab4f55839b7ae6bd4,
title = "Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E",
abstract = "We studied whether circulating activated platelets and platelet-leukocyte aggregates cause the development of atherosclerotic lesions in apolipoprotein-E-deficient (Apoe-/-) mice. Circulating activated platelets bound to leukocytes, preferentially monocytes, to form platelet-monocyte/leukocyte aggregates. Activated platelets and platelet-leukocyte aggregates interacted with atherosclerotic lesions. The interactions of activated platelets with monocytes and atherosclerotic arteries led to delivery of the platelet-derived chemokines CCL5 (regulated on activation, normal T cell expressed and secreted, RANTES) and CXCL4 (platelet factor 4) to the monocyte surface and endothelium of atherosclerotic arteries. The presence of activated platelets promoted leukocyte binding of vascular cell adhesion molecule-1 (VCAM-1) and increased their adhesiveness to inflamed or atherosclerotic endothelium. Injection of activated wild-type, but not P-selectin-deficient, platelets increased monocyte arrest on the surface of atherosclerotic lesions and the size of atherosclerotic lesions in Apoe-/- mice. Our results indicate that circulating activated platelets and platelet-leukocyte/monocyte aggregates promote formation of atherosclerotic lesions. This role of activated platelets in atherosclerosis is attributed to platelet P-selectin-mediated delivery of platelet-derived proinflammatory factors to monocytes/leukocytes and the vessel wall.",
author = "Yuqing Huo and Andreas Schober and Forlow, {S. Bradley} and Smith, {David F.} and Hyman, {Matthew Craig} and Steffen Jung and Littman, {Dan R.} and Christian Weber and Klaus Ley",
year = "2003",
month = "1",
day = "1",
doi = "10.1038/nm810",
language = "English (US)",
volume = "9",
pages = "61--67",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E

AU - Huo, Yuqing

AU - Schober, Andreas

AU - Forlow, S. Bradley

AU - Smith, David F.

AU - Hyman, Matthew Craig

AU - Jung, Steffen

AU - Littman, Dan R.

AU - Weber, Christian

AU - Ley, Klaus

PY - 2003/1/1

Y1 - 2003/1/1

N2 - We studied whether circulating activated platelets and platelet-leukocyte aggregates cause the development of atherosclerotic lesions in apolipoprotein-E-deficient (Apoe-/-) mice. Circulating activated platelets bound to leukocytes, preferentially monocytes, to form platelet-monocyte/leukocyte aggregates. Activated platelets and platelet-leukocyte aggregates interacted with atherosclerotic lesions. The interactions of activated platelets with monocytes and atherosclerotic arteries led to delivery of the platelet-derived chemokines CCL5 (regulated on activation, normal T cell expressed and secreted, RANTES) and CXCL4 (platelet factor 4) to the monocyte surface and endothelium of atherosclerotic arteries. The presence of activated platelets promoted leukocyte binding of vascular cell adhesion molecule-1 (VCAM-1) and increased their adhesiveness to inflamed or atherosclerotic endothelium. Injection of activated wild-type, but not P-selectin-deficient, platelets increased monocyte arrest on the surface of atherosclerotic lesions and the size of atherosclerotic lesions in Apoe-/- mice. Our results indicate that circulating activated platelets and platelet-leukocyte/monocyte aggregates promote formation of atherosclerotic lesions. This role of activated platelets in atherosclerosis is attributed to platelet P-selectin-mediated delivery of platelet-derived proinflammatory factors to monocytes/leukocytes and the vessel wall.

AB - We studied whether circulating activated platelets and platelet-leukocyte aggregates cause the development of atherosclerotic lesions in apolipoprotein-E-deficient (Apoe-/-) mice. Circulating activated platelets bound to leukocytes, preferentially monocytes, to form platelet-monocyte/leukocyte aggregates. Activated platelets and platelet-leukocyte aggregates interacted with atherosclerotic lesions. The interactions of activated platelets with monocytes and atherosclerotic arteries led to delivery of the platelet-derived chemokines CCL5 (regulated on activation, normal T cell expressed and secreted, RANTES) and CXCL4 (platelet factor 4) to the monocyte surface and endothelium of atherosclerotic arteries. The presence of activated platelets promoted leukocyte binding of vascular cell adhesion molecule-1 (VCAM-1) and increased their adhesiveness to inflamed or atherosclerotic endothelium. Injection of activated wild-type, but not P-selectin-deficient, platelets increased monocyte arrest on the surface of atherosclerotic lesions and the size of atherosclerotic lesions in Apoe-/- mice. Our results indicate that circulating activated platelets and platelet-leukocyte/monocyte aggregates promote formation of atherosclerotic lesions. This role of activated platelets in atherosclerosis is attributed to platelet P-selectin-mediated delivery of platelet-derived proinflammatory factors to monocytes/leukocytes and the vessel wall.

UR - http://www.scopus.com/inward/record.url?scp=0037231665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037231665&partnerID=8YFLogxK

U2 - 10.1038/nm810

DO - 10.1038/nm810

M3 - Article

C2 - 12483207

AN - SCOPUS:0037231665

VL - 9

SP - 61

EP - 67

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 1

ER -